Walgreens Announces Collaboration with Centers for Disease Control and Prevention to Improve HIV Prevention and Outcomes
December 16 2013 - 12:04PM
Business Wire
Walgreens and CDC to Evaluate HIV Care Model at
More Than 700 HIV-Specialized Pharmacies
In support of the more than 1.1 million people living with HIV
in the U.S., Walgreens (NYSE: WAG) (Nasdaq: WAG) is collaborating
with the Centers for Disease Control and Prevention (CDC) to
develop and evaluate a model of HIV patient-centered care through a
national project aimed at advancing clinical integration and
medication therapy management. The program is another way Walgreens
is extending its commitment to improve HIV prevention and treatment
outcomes.
Walgreens is leveraging the expertise of its more than 700
HIV-specialized pharmacies and specially trained pharmacists to
lead medication care plans and provide data evaluation and outcomes
reporting for 1,000 HIV positive project participants. Walgreens
pharmacists, who routinely provide pharmacy care and treatment for
people living with HIV, will meet one-on-one with project
participants to create care plans that focus on medication
adherence and address other needs including health education for
added chronic conditions.
“Our approach to improving HIV prevention and treatment is
individualized care focused on the holistic needs of patients,”
said Glen Pietrandoni, senior manager, virology, Walgreens. “Beyond
dispensing medication, our pharmacists are trained to provide
testing, confidential wellness consultations, coordinate care and
benefits with physicians and insurance providers, and to help
patients access financial support programs to reduce medication
costs. However, medication adherence remains our primary objective
because we know that taking the right medication at the right time
is key to improving health outcomes.”
A Walgreens study of more than 15,000 HIV patients showed that
those who received care through one of its HIV-specialized
pharmacies, with expert-level trained pharmacists, were
significantly more adherent to their medication (74 percent) than
those receiving care through a traditional, non-specialized
Walgreens pharmacy (69 percent).1 Adherent HIV patients are more
likely to achieve improved health outcomes and suppressed viral
loads, which make the virus less likely to be transmittable. 1
However, the CDC estimates only 25 percent of Americans with HIV
have the virus under control.2
Walgreens collaboration with the CDC supports the goals the
National HIV/AIDS Strategy and underscores its commitment to
support communities affected by HIV/AIDS. Its HIV-specialized
pharmacies continue to cooperate with local health departments and
AIDS service organizations to support HIV testing and community
events, and work with local health care providers, government
leaders and religious organizations to continually assess and meet
the needs of individuals in select communities throughout the
U.S.
About Walgreens
As the nation's largest drugstore chain with fiscal 2013 sales
of $72 billion, Walgreens (www.walgreens.com) vision is to be the
first choice in health and daily living for everyone in America,
and beyond. Each day, Walgreens provides more than 6 million
customers the most convenient, multichannel access to consumer
goods and services and trusted, cost-effective pharmacy, health and
wellness services and advice in communities across America.
Walgreens scope of pharmacy services includes retail, specialty,
infusion, medical facility and mail service, along with respiratory
services. These services improve health outcomes and lower costs
for payers including employers, managed care organizations, health
systems, pharmacy benefit managers and the public sector. The
company operates 8,197 drugstores in all 50 states, the District of
Columbia, Puerto Rico and the U.S. Virgin Islands. Take Care Health
Systems is a Walgreens subsidiary that is the largest and most
comprehensive manager of worksite health and wellness centers,
provider practices, and in-store convenient care clinics, with more
than 750 locations throughout the country.
1. Murphy P, Cocohoba J, Tang M, et al. Impact of
HIV-specialized pharmacies on adherence and persistence with
antiretroviral therapy. AIDS PatientCare and STDs, Volume 26,
Number 9, 2012.
2. Hall HI, Frazier EL, Rhodes P, et al. Differences in human
immunodeficiency virus care and treatment among subpopulations in
the United States. JAMA Intern Med. 2013 Jul 22;173(14):1337-44.
doi: 10.1001/jamainternmed.2013.6841.
WalgreensMarkeisha Marshall, (847)
315-2923http://news.walgreens.com@WalgreensNewsfacebook.com/Walgreens
West Africa Gold (NASDAQ:WAGI)
Historical Stock Chart
From Jun 2024 to Jul 2024
West Africa Gold (NASDAQ:WAGI)
Historical Stock Chart
From Jul 2023 to Jul 2024